Zapping acupoints may ease period pain for autoimmune patients
NCT ID NCT06976151
First seen May 01, 2026 · Last updated Jun 22, 2026 · Updated 8 times
Summary
This study tested whether transcutaneous electrical acupoint stimulation (TEAS) — a gentle electrical pulse applied to specific points on the body — could reduce period pain and inflammation in women with autoimmune diseases like rheumatoid arthritis or lupus. Fifty-two women received either standard painkillers alone or painkillers plus TEAS sessions three times a week. Researchers measured pain, walking speed, and blood markers of inflammation over three menstrual cycles.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lamiaa Mostafa Okeil
Al Fayyum, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Transcutaneous electrical acupoint stimulation (TEAS) plus diclofenac (NSAID)
What this could lead to
If it works, this could offer a drug-free add-on to help manage painful periods in women with autoimmune conditions.
What could go wrong
This is a small, completed trial with only 52 participants, so results may not apply to everyone. The treatment is an add-on to standard painkillers, not a replacement.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.